Intel Corporation v. Proxense, LLC

Tempus AI, Inc.vsGuardant Health Inc.

Guardant Health settled its digital sequencing patent dispute with Foundation Medicine for $25 million plus royalties, granting a non‑exclusive license and dismissing all related litigation.

Samsung Electronics Co., Ltd et al.vsSecure Communication Technologies, LLC

Samsung and Secure Communication Technologies have jointly filed a request to keep their settlement agreement confidential under 35 U.S.C. § 317(b), separating it from the IPR file for patent 11,334,918.

3Shape A/S et al.vsMedit Corporation et al.

Petitioners, including 3Shape A/S, have filed an IPR challenging the validity of Medit Corporation's patent claims related to 3D scanning and stitching technology. The central argument asserts that the claimed invention is obvious over prior art references Kriveshko and Zhang when combining global motion optimization techniques. This challenges the scope of a major patent in the computer vision market.

Western Digital Technologies, Inc. et al.vsGodo Kaisha IP Bridge 1

Western Digital has filed an IPR petition seeking cancellation of all four claims of U.S. Patent 8,405,134, which covers MRAM technology. The petition argues the claims are obvious over prior‑art references Bowen, Nagahama, Sunai, and Parkin, and challenges any discretionary denial of institution.

Fresenius Kabi SwissBioSim GmbH et al.vsRegeneron Pharmaceuticals, Inc.

Fresenius Kabi SwissBioSim petitions the PTAB to invalidate Regeneron’s anti‑VEGF eye‑drug patent, asserting that the Dix ’226 reference anticipates all challenged claims and that the patent owner has not shown any criticality for the claimed formulation parameters.